TY  - GEN
AU  - Kereiakes,Dean J
AU  - Sudhir,Krishnankutty
AU  - Hermiller,James B
AU  - Gordon,Paul C
AU  - Ferguson,Joanne
AU  - Yaqub,Manejeh
AU  - Sood,Poornima
AU  - Su,Xiaolu
AU  - Yakubov,Steven
AU  - Lansky,Alexandra J
AU  - Stone,Gregg W
TI  - Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials
SN  - 1876-7605
PY  - 2011///0509
KW  - Angioplasty, Balloon, Coronary
KW  - Antineoplastic Agents, Phytogenic
KW  - administration & dosage
KW  - Coronary Artery Bypass
KW  - Coronary Artery Disease
KW  - drug therapy
KW  - Drug-Eluting Stents
KW  - Everolimus
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Paclitaxel
KW  - Randomized Controlled Trials as Topic
KW  - Sirolimus
KW  - Time Factors
KW  - United States
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.jcin.2010.09.014
ER  -